EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor

Lena Wucherpfennig, Johanna K Z Becker, Felix Wuennemann, Monika Eichinger, Angelika Seitz, Ingo Baumann, Mirjam Stahl, Simon Y Graeber, Shengkai Zhao, Jaehi Chung, Jens-Peter Schenk, Abdulsattar Alrajab und 4 weitere

Journal of Cystic Fibrosis · 2024

DOI: 10.1016/j.jcf.2024.01.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2024. Verfasst von Lena Wucherpfennig und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Im Neuenheimer Feld 420, Heidelberg 69120, Germany; Translatio…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Aminophenols, Magnetic Resonance Imaging, Quinolones. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung Dienststelle Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Previous studies using magnetic resonance imaging (MRI) demonstrated early onset and progression of chronic rhinosinusitis (CRS) from infancy to school age, and response to lumacaftor/ivacaftor (LUM/IVA) therapy in children with cystic fibrosis (CF). However, the effect of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) on CRS detected by MRI in children with CF and at least one F508del mutation, and potential incremental effects of ELX/TEZ/IVA compared to LUM/IVA in F508del homozygous children have not been studied. METHODS: 30 children with CF with at least one F508del mutation underwent three longitudinal paranasal sinus MRI before (MRI1), without (n = 16) or with LUM/IVA therapy (n = 14, MRI2), and with ELX/TEZ/IVA therapy (MRI3, mean age at therapy initiation 11.1 ± 3.4y, range 6-16y). MRI were evaluated using the CRS-MRI score. RESULTS: After therapy initiation with ELX/TEZ/IVA, the prevalence and in maxillary and sphenoid sinuses the dominance of mucopyoceles decreased (35% vs. 0 %, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisAminophenolsMagnetic Resonance ImagingQuinolonesBenzodioxolesSinusitisDrug CombinationsRhinitisAminopyridinesPyrazolesIndolesHumansMaleFemaleChildChronic DiseaseChloride Channel AgonistsAdolescentPyridinesTreatment OutcomeRhinosinusitisPyrrolidines

Stichwörter der Autor:innen

Airway diseaseChronic rhinosinusitisCystic fibrosisMagnetic resonance imagingMucus obstruction

Substanzen

AminophenolsQuinolonesBenzodioxolesDrug CombinationsAminopyridinesPyrazolesIndolesChloride Channel AgonistsPyridinesPyrrolidines

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Im Neuenheimer Feld 420, Heidelberg 69120, Germany; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Res…
  • Department of Neuroradiology, University Hospital Heidelberg, Im Neuenheimer Feld 400, Heidelberg 69120, Germany.
  • Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 400, Heidelberg 69120, Germany.
  • Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin 13353, Germany; German Center for Lung Research (DZL) associated pa…
  • Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Im Neuenheimer Feld 156, Heidelberg 69120, Germany; Division of Pediatric Pulmonology & Allergy and Cystic Fibrosis Center, De…
  • Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Im Neuenheimer Feld 420, Heidelberg 69120, Germany.

Förderung

  • Bundesministerium für Bildung und Forschung Dienststelle Berlin

Zitieren

APA

Wucherpfennig, L., Becker, J. K. Z., Wuennemann, F., Eichinger, M., Seitz, A., Baumann, I., Stahl, M., Graeber, S. Y., Zhao, S., Chung, J., Schenk, J. P., Alrajab, A., Kauczor, H. U., Mall, M. A., Sommerburg, O., & Wielpütz, M. O. (2024). Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2024.01.004

Vancouver

Wucherpfennig L, Becker JKZ, Wuennemann F, Eichinger M, Seitz A, Baumann I, et al. Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor. Journal of Cystic Fibrosis. 2024. doi:10.1016/j.jcf.2024.01.004

BibTeX
@article{Wucherpfennig2024,
  author = {Wucherpfennig, Lena and Becker, Johanna K Z and Wuennemann, Felix and Eichinger, Monika and Seitz, Angelika and Baumann, Ingo and Stahl, Mirjam and Graeber, Simon Y and Zhao, Shengkai and Chung, Jaehi and Schenk, Jens-Peter and Alrajab, Abdulsattar and Kauczor, Hans-Ulrich and Mall, Marcus A and Sommerburg, Olaf and Wielpütz, Mark O},
  title = {Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor},
  journal = {Journal of Cystic Fibrosis},
  year = {2024},
  doi = {10.1016/j.jcf.2024.01.004}
}
Kostenlos starten →